Intervention-Related Changes in Coping Ability Drives Improvements in Mood and Quality of Life for Patients Taking Adjuvant Endocrine Therapy

被引:0
|
作者
Walsh, Leah E. [1 ]
Dunderdale, Laura [2 ]
Horick, Nora [2 ,3 ]
Temel, Jennifer S. [2 ,3 ]
Greer, Joseph A. [2 ,3 ]
Jacobs, Jamie M. [2 ,3 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Massachusetts Gen Hosp, Boston, MA USA
[3] Harvard Med Sch, Boston, MA USA
基金
美国国家卫生研究院;
关键词
adjuvant endocrine therapy; breast cancer; cancer; coping skills; mediation; mood; oncology; quality of life; self-efficacy; COGNITIVE-BEHAVIORAL THERAPY; BREAST-CANCER; SYMPTOMS; DEPRESSION; MANAGEMENT; ADHERENCE; WOMEN; SURVIVORS; DISTRESS; ANXIETY;
D O I
10.1002/pon.70049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveA recent randomized trial of a group psychosocial telehealth intervention (STRIDE) improved anxiety, depression, quality of life (QOL), symptom distress, coping, and self-efficacy to manage symptoms related to taking adjuvant endocrine therapy (AET) in women with non-metastatic hormone receptor-positive breast cancer. This study examined whether changes in coping and self-efficacy mediated intervention effects on anxiety, depression, QOL, and symptom distress.MethodWomen (N = 100) were recruited between 10/2019-06/2021 from Massachusetts General Hospital and were randomized to STRIDE or to the medication monitoring control group. Participants completed self-report measures of anxiety and depression (Hospital Anxiety and Depression Scale), QOL (Functional Assessment of Cancer Therapy-Breast Cancer scale), symptom distress (Breast Cancer Prevention Trial Symptom Scale), coping (Measure of Current Status-Part A), and self-efficacy (Self Efficacy for Managing AET Symptoms) at baseline and 24-week follow-up. Mediated regression models tested whether changes in coping ability and self-efficacy mediated the intervention effects on anxiety, depression, QOL, and symptom distress, controlling for key variables.ResultsImprovements in coping across the 24-week study period mediated the effect of STRIDE on anxiety symptoms (indirect effect, B = -0.61, SE = 0.28, 95% CI: -1.28, -0.17), depressive symptoms (indirect effect, B = -0.50, SE = 0.21, 95% CI: -0.97, -0.15), and QOL (indirect effect, B = 3.80, SE = 1.25, 95% CI: 1.54, 6.49), but not symptom distress. Changes in self-efficacy did not mediate improvements in any of the proposed outcomes.ConclusionCoping is an essential component of a brief group psychosocial intervention that drives improvements in mood and QOL for women with non-metastatic hormone receptor-positive breast cancer taking AET.Clinical trial registrationNCT03837496.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Intervention-Related Improvements in Adherence to Adjuvant Endocrine Therapy for Women 55+on Aromatase Inhibitors
    Jacobs, Jamie
    Massad, Katina
    Horick, Nora
    Cohn, Julia
    Walsh, Emily
    Rapoport, Chelsea
    Post, Kathryn
    Comander, Amy
    Antoni, Michael
    Safren, Steven
    Partridge, Ann
    Peppercorn, Jeffrey
    Park, Elyse
    Temel, Jennifer
    Greer, Joseph
    PSYCHO-ONCOLOGY, 2022, 31 : 72 - 72
  • [2] Evaluation of the Effects of a Psychosocial Intervention on Mood, Coping, and Quality Of Life in Cancer Patients
    Reavley, Nicola
    Pallant, Julie F.
    Sali, Avni
    INTEGRATIVE CANCER THERAPIES, 2009, 8 (01) : 47 - 55
  • [3] Adjuvant endocrine therapy adherence changes among patients after a virtual behavioral intervention
    Jacobs, Jamie M.
    Walsh, Emily A.
    Horick, Nora K.
    Post, Kathryn Elizabeth
    Antoni, Michael
    Safren, Steven A.
    Partridge, Ann H.
    Peppercorn, Jeffrey M.
    Park, Elyse R.
    Temel, Jennifer S.
    Greer, Joseph A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] EXPECTED SYMPTOM COPING AND QUALITY OF LIFE IN BREAST CANCER PATIENTS RECEIVING ENDOCRINE THERAPY
    Schuricht, F.
    Von Blanckenburg, P.
    Albert, U-S.
    Rief, W.
    Nestoriuc, Y.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2012, 19 : S170 - S170
  • [5] Effects of adjuvant endocrine therapy on depression and quality of life in early breast cancer patients
    Ristevska-Dimitrovska, G.
    Stefanovski, P.
    Smichkoska, S.
    Dejanova, B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S403 - S403
  • [6] Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients
    Kool, M.
    Fontein, D. B. Y.
    Kranenbarg, E. Meershoek-Klein
    Nortier, J. W. R.
    Rutgers, E. J. T.
    Marang-van de Mheen, P. J.
    van de Velde, C. J. H.
    BREAST, 2015, 24 (03): : 224 - 229
  • [7] Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
    Annelieke A. Lemij
    Nienke A. de Glas
    Marloes G. M. Derks
    Esther Bastiaannet
    Jos W. S. Merkus
    Titia E. Lans
    Carmen C. van der Pol
    Thijs van Dalen
    Annelie J. E. Vulink
    Leander van Gerven
    Onno R. Guicherit
    Eugenie M. H. Linthorst-Niers
    Frederiek van den Bos
    Judith R. Kroep
    Gerrit Jan Liefers
    Johanneke E. A. Portielje
    Breast Cancer Research and Treatment, 2022, 193 : 567 - 577
  • [8] Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer
    Lemij, Annelieke A.
    de Glas, Nienke A.
    Derks, Marloes G. M.
    Bastiaannet, Esther
    Merkus, Jos W. S.
    Lans, Titia E.
    van der Pol, Carmen C.
    van Dalen, Thijs
    Vulink, Annelie J. E.
    van Gerven, Leander
    Guicherit, Onno R.
    Linthorst-Niers, Eugenie M. H.
    van den Bos, Frederiek
    Kroep, Judith R.
    Liefers, Gerrit Jan
    Portielje, Johanneke E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (03) : 567 - 577
  • [9] Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy
    Di Meglio, Antonio
    Soldato, Davide
    Presti, Daniele
    Vaz-Luis, Ines
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (06) : 553 - 573
  • [10] Adjuvant endocrine therapy in pre menopausal breast cancer patients; Menopausal symptoms and quality of life.
    Nystedt, M
    Bolund, C
    Berglund, G
    Brandberg, Y
    Fornander, T
    Rutqvist, LE
    PSYCHO-ONCOLOGY, 1998, 7 (03) : 157 - 157